Crossmark Global Holdings, Inc. Dexcom Inc Transaction History

Crossmark Global Holdings, Inc.

$6.02 Billion
Q2 2025

A detailed history of Crossmark Global Holdings, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 19,773 shares of DXCM stock, worth $1.31 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

19,773

Previous 18,637 6.1%

Holding current value

$1.31 Million

Previous $1.27 Million 35.61%

% of portfolio

0.03%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$59.83 - $87.57 $67,966 - $99,479	1,136 Added 6.1%	19,773 $1.73 Million
Q1 2025 Apr 29, 2025	SELL	$67.74 - $90.75 $6,164 - $8,258	-91 Reduced 0.49%	18,637 $1.27 Million
Q4 2024 Jan 16, 2025	SELL	$65.68 - $81.01 $3,284 - $4,050	-50 Reduced 0.27%	18,728 $1.46 Million
Q3 2024 Nov 04, 2024	BUY	$64.0 - $116.06 $11,648 - $21,122	182 Added 0.98%	18,778 $1.26 Million
Q2 2024 Jul 29, 2024	BUY	$110.31 - $140.45 $18,973 - $24,157	172 Added 0.93%	18,596 $2.11 Million
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $61,793 - $75,794	-541 Reduced 2.85%	18,424 $2.56 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $110,290 - $181,397	-1,461 Reduced 7.15%	18,965 $2.35 Million
Q3 2023 Nov 08, 2023	SELL	$86.06 - $137.93 $19,019 - $30,482	-221 Reduced 1.07%	20,426 $1.74 Million
Q2 2023 Jul 31, 2023	BUY	$112.47 - $130.98 $16,982 - $19,777	151 Added 0.74%	20,647 $2.73 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $77,272 - $91,329	-743 Reduced 3.5%	20,496 $2.38 Million
Q4 2022 Jan 19, 2023	BUY	$84.98 - $122.67 $16,061 - $23,184	189 Added 0.9%	21,239 $2.41 Million
Q3 2022 Nov 01, 2022	SELL	$76.35 - $94.18 $28,249 - $34,846	-370 Reduced 1.73%	21,050 $1.7 Million
Q2 2022 Jul 29, 2022	BUY	$67.99 - $132.89 $1.09 Million - $2.14 Million	16,081 Added 301.2%	21,420 $1.6 Million
Q1 2022 May 11, 2022	BUY	$94.08 - $130.2 $7,526 - $10,416	80 Added 1.52%	5,339 $2.73 Million
Q4 2021 Jan 10, 2022	SELL	$129.87 - $162.82 $541,557 - $678,959	-4,170 Reduced 44.23%	5,259 $2.82 Million
Q3 2021 Oct 21, 2021	BUY	$106.71 - $143.18 $1.01 Million - $1.35 Million	9,429 New	9,429 $5.16 Million
Q3 2021 Oct 13, 2021	SELL	$106.71 - $143.18 $1.09 Million - $1.46 Million	-10,199 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$80.99 - $107.93 $54,182 - $72,205	-669 Reduced 6.16%	10,199 $4.36 Million
Q1 2021 Apr 15, 2021	SELL	$84.79 - $104.74 $98,356 - $121,498	-1,160 Reduced 9.64%	10,868 $3.91 Million
Q4 2020 Jan 14, 2021	BUY	$78.0 - $104.5 $247,260 - $331,265	3,170 Added 35.79%	12,028 $4.45 Million
Q3 2020 Oct 08, 2020	BUY	$95.51 - $112.95 $19,579 - $23,154	205 Added 2.37%	8,858 $3.65 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $542,370 - $911,507	8,653 New	8,653 $3.51 Million
Q4 2018 Jan 31, 2019	SELL	$26.99 - $37.37 $49,904 - $69,097	-1,849 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$23.35 - $36.72 $43,174 - $67,895	1,849 New	1,849 $264,000

Others Institutions Holding DXCM

# of Institutions

1,108

Shares Held

368M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Dexcom Inc Transaction History